RECENT NEWS
Delivering a diagnostic cytopathology service
The Institute of Biomedical Science (IBMS), Royal College of Pathologists (RCPath) and British Association for Cytopathology (BAC) have combined to release a joint statement to guide the delivery of diagnostic cytopathology services across England.
Deep learning reveals valuable clues about kidney cancer in pathology slides
A team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC; pictured) using image processing with deep learning.
New pathway to quicken NHS access to innovative medical technology
The Innovative Devices Access Pathway (IDAP) pilot has been launched, supported by £10 million of Government funding, with the aim of expediting UK patient access to innovative technologies by providing innovators and manufacturers with multi-partner support and targeted scientific advice.
The BJBS Publishing Prize 2024
The British Journal of Biomedical Science is excited to announce a new award for biomedical Scientists at the start of their research career. The BJBS Publishing Prize aims to inspire biomedical scientists at the start of their research careers to submit their research to the journal.
Are you ready for IBMS Congress?
IBMS Congress starts next week, with the key event of the year on the laboratory medicine calendar taking place at the Birmingham ICC between 25-28 September.
Evident announces alliance to automate digital pathology workflows
Imaging firm Evident has announced an alliance with Corista, Sakura Finetek USA and Visiopharm to deliver an automated, end-to-end workflow solution for pathology in the USA. Together, the scientific leaders will combine their technologies to streamline the workflow of staining, imaging, and analysing whole slide images with the collaboration and management needed in today’s high-volume laboratories.
HORIBA UK expands clinical chemistry portfolio with new POINTE G6PD assay kit
HORIBA UK has expanded its clinical chemistry portfolio with the addition of a new test kit for glucose-6-phosphate dehydrogenase (G6PD) from Pointe Scientific. Used for the quantitative determination of G6PD enzyme activity in blood, the CE-marked POINTE G6PD assay kit combines everything required for undertaking G6PD testing, excluding controls, in a single box.
Leica Biosystems’ BOND-PRIME staining solution makes UK debut at IBMS Congress
The new BOND-PRIME Advanced Staining Solution from Leica Biosystems has its first event unveiling at this year’s IBMS Congress (stand 608). BOND-PRIME is a faster, more advanced staining solution, featuring all elements of Universal Access – able to handle any slide, in any combination, at any time, using any reagent.
Aiosyn introduces kidney AI platform for renal disease research
AI-powered pathology solutions provider Aiosyn has announced the release of an AI kidney suite designed to advance research in the field of renal disease. Leveraging cutting-edge deep learning technology, this solution provides biopharma and research organisations with powerful tools for analysing kidney structures and quantifying lesions that impact kidney health.
Navigate BioPharma and BD to collaborate on developing flow cytometry
US-based laboratory Navigate BioPharma Services has announced a strategic collaboration with medical technology company BD (Becton, Dickinson and Company) to develop and commercialise flow cytometry-based companion diagnostics and tools for clinical decisions.
Agilent agrees sale of Resolution Bioscience to Exact Sciences
Agilent Technologies and Exact Sciences Corp, a leading provider of cancer screening and diagnostic tests, have announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences.
Report reveals impact of COVID-19 research and innovation funding
A new independent report released by UKRI underscores the pivotal role played by UK researchers and innovators in tackling the pandemic.
ELRIG UK establishes engagement strategy work group
The European Laboratory Research & Innovation Group (ELRIG) UK has announced the formation of its Engagement Strategy Work Group (ESWG). The group will provide strategic direction and guidance to help ensure the ELRIG community continues to grow and thrive.
Giving clinicians critical information faster
Point-of-care (POC)-based blood gas analysers can support emergency department (ED) clinicians to make timely diagnoses to manage patient flow and ease overcrowding.
University of Limerick and Dell collaborate on predictive and diagnostic cancer research
Dell Technologies has joined forces with the University of Limerick's Digital Cancer Research Centre to develop an artificial intelligence (AI) platform and digital twin technology to power predictive and diagnostic research in oncology.
MRC innovation funding to tackle hard-to-treat cancers
The Medical Research Council (MRC) has announced a new £2 million investment supporting researchers to understand and treat cancers with exceptionally poor survival rates, including of the brain, lung and oesophagus. Four research innovation teams will each receive £500,000 to work across disciplines on high-risk, high-reward projects towards improving outcomes of hard-to-treat cancers.
Randox set to release eight new Quality Controls
Randox offers an extensive product offering comprising third-party quality controls and calibrators, interlaboratory data management, external quality assessment, calibration verification and molecular IQC and EQA for infectious disease testing. Randox Quality Control is now set to add eight Quality Controls to its range.
IBMS launches training grant programme
The Institute of Biomedical Science (IBMS) is launching a new grant to support the development of training solutions to support all staff working within biomedical science.
HORIBA celebrates anniversary at Congress with new haemostasis analysers
HORIBA UK will be marking its 70th anniversary at IBMS Congress later this month, where delegates are invited to join the celebrations and also to see the company’s newly launched fully automated haemostasis analysers.
Doris-Ann Williams steps down from BIVDA
Doris-Ann Williams has retired from her role as Chief Executive at BIVDA, after almost 22 years.
Featured Supplier
BD offers a flexible and scalable approach to IV barcoding with the Alaris™ Auto-ID module. This unique barcoding device narrows the uncertainty between the right drug and right patient and also helps to ensure that only authorized hospital personnel administer the medication providing an additional safety net for all pump, syringe and PCA...
Upcoming Events
IBMS Congress 2023 - Linking learning to the laboratory
ICC Birmingham
25-28 September 2023
BIVDA Annual Regulatory Affairs Seminar
The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023
Drug Discovery 2023
ACC Exhibition Centre, Liverpool
18-19 October
MEEGID XVI
Hilton Dresden, Germany
14-17 November 2023
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
